Trulicity 1.5 Mg

Trulicity 1.5 Mg

Trulicity 1.5 Mg is a once-weekly injectable medication containing dulaglutide, used for the management of type 2 diabetes mellitus. It belongs to the GLP-1 receptor agonist class, which helps regulate blood sugar levels and supports weight management. This higher strength is prescribed when lower doses like Trulicity 0.75 Mg are not sufficient for glycemic control. It offers convenient dosing and is widely used in modern diabetes care. In treatment plans, alternative therapies such as Victoza Pen may also be considered depending on patient needs.

Mechanism of Action

GLP-1 Receptor Activation

Trulicity mimics the natural GLP-1 hormone, increasing insulin secretion after meals.

Blood Sugar Regulation

It reduces glucose production in the liver and slows gastric emptying, helping maintain stable blood sugar levels. For clinical insights, refer to American Diabetes Association (ADA) and for safety guidance, consult Mayo Clinic – Dulaglutide Information.

Medical Uses

Trulicity 1.5 Mg is used for:

• Type 2 diabetes mellitus
• Blood sugar control
• Weight management support
• Combination therapy with other antidiabetic medications

It is commonly prescribed for long-term diabetes management.

Dosage and Administration

Trulicity 1.5 Mg is injected subcutaneously once weekly, with or without food, as directed by a healthcare provider. The dose is adjusted based on patient response and tolerance. In clinical practice, Trulicity 0.75 Mg is used as a starting dose, while Victoza Pen may be used as an alternative GLP-1 therapy.

Clinical Effectiveness

Clinical studies show that dulaglutide effectively lowers blood sugar levels, improves HbA1c, and supports weight reduction when used consistently.

Safety and Side Effects

Common Side Effects

• Nausea
• Vomiting
• Diarrhea
• Decreased appetite

Serious Risks

• Pancreatitis (rare)
• Thyroid tumors (in animal studies)

Regular monitoring is recommended. For more details, refer to Mayo Clinic – Dulaglutide Information.

Contraindications and Precautions

Trulicity 1.5 Mg should be used with caution in:

• Patients with a history of thyroid cancer
• Individuals with severe gastrointestinal disorders
• Patients with pancreatitis history

Consult a healthcare provider before use.

Drug Interactions

Trulicity may interact with medications affecting blood sugar levels or digestion. Patients should inform their healthcare provider about all medicines they are taking. For further reading, refer to American Diabetes Association (ADA).

FAQs